HealthcareMachine Learning
Cure51 Achieves 17x Speedup in Genomic Analysis Using NVIDIA DGX Cloud
Cure51
Cure51, a Paris-based Sofinnova portfolio company, achieved a 17x speedup in genomic analysis and 2x cost savings by shifting workloads to NVIDIA Parabricks running on NVIDIA DGX Cloud, accessed through the DGX Cloud Lepton program for top European healthcare and life sciences venture-backed startups, which offers access to NVIDIA H100 GPU nodes and white-glove support to help scale into markets requiring sovereign, localized compute.
